Exchange: NASDAQ·Updated 04:04 AM EDT
EVER logo

EVEREverQuote Inc - Ordinary Shares - Class A

$23.91
$0.12
(0.50%)
Pre-Market
Prev Close $23.79
EarningsAug 3
Mkt Cap$825.26M
Vol26.00
News
all
press releases
Strength Seen in EverQuote (EVER): Can Its 6.9% Jump Turn into More Strength?
EverQuote (EVER) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
News Placeholder
More News
News Placeholder
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
CAL, GIII, NUS, APLE and EVER screen as low price-to-sales value stocks with upside potential, backed by valuation and debt filters.
Zacks
News Placeholder
Why Is EverQuote (EVER) Down 20.2% Since Last Earnings Report?
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Surging Earnings Estimates Signal Upside for EverQuote (EVER) Stock
EverQuote (EVER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
News Placeholder
Wall Street Analysts See a 29.47% Upside in EverQuote (EVER): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 29.5% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains
Price-to-sales screens can uncover discounted growth when earnings are thin, pairing low P/S with balance-sheet and value checks for upside.
Zacks
News Placeholder
EverQuote Sees Insurance Carrier Comeback Fueling Growth Toward $1B Revenue
EverQuote Sees Insurance Carrier Comeback Fueling Growth Toward $1B Revenue...
Yahoo! Finance: News
News Placeholder
Lemonade Stock Plunges 16% in 3 Months: Time to Buy the Dip?
Lemonade shares slid 15.9% in 3 months. AI-driven growth, rising in-force premium and 2026 revenue outlook clash with a premium valuation.
Zacks
News Placeholder
EverQuote (NASDAQ:EVER) Stock Price Down 12.7% - Time to Sell?
EverQuote (NASDAQ:EVER) Trading Down 12.7% - Here's What Happened...
MarketBeat
News Placeholder
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for EverQuote (NASDAQ:EVER) Stock
JPMorgan Chase & Co. raised their price target on EverQuote from $22.00 to $24.00 and gave the stock an "overweight" rating in a research note on Tuesday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.